MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$11,704,565
Net Income
-$4,021,360
Net Profit Margin
-34.36%
EPS
-$0.09
Unit: Dollar
Revenue Breakdown
Direct To Patient
Clinical And Medical Providers
Revenue Breakdown
gross profit
cost of revenue
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
11,704,565
10,113,288
11,353,295
10,090,699
Cost of revenue
3,262,017
3,211,682
3,569,022
3,648,451
Gross profit
8,442,548
6,901,606
7,784,273
6,442,248
Research and development
1,720,463
1,623,160
1,624,823
1,527,660
Selling, clinical and marketing
5,264,090
4,816,759
5,501,163
5,254,246
General and administrative
3,712,481
3,618,739
3,432,046
3,177,856
Total operating expenses
10,697,034
10,058,658
10,558,032
9,959,762
Loss from operations
-2,254,486
-3,157,052
-2,773,759
-3,517,514
Interest expense (income), net
-535,744
-504,696
-739,629
-9,743
Change in fair value of derivative liabilities
-
839,064
-216,673
-
Change in fair value of derivatives liabilities
-1,199,726
-
-
-
Total other (income), net
-1,735,470
334,368
-956,302
-9,743
Loss before income taxes
-3,989,956
-2,822,684
-3,730,061
-3,527,257
Income tax expense
31,404
186,715
83,878
135,658
Net loss
-4,021,360
-3,009,399
-3,813,939
-3,662,915
Basic EPS
-0.09
-0.07
-0.09
-0.09
Diluted EPS
-0.09
-0.07
-0.09
-0.09
Basic Average Shares
42,697,319
42,269,133
42,217,099
42,168,120
Diluted Average Shares
42,697,319
42,269,133
42,217,099
42,168,120
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
MYO Income Statement Sankey Diagram
Sankey diagram visualizing MYO income statement for the period
Net loss
-$4,021,360
(13.18%↑ Y/Y)
Direct To Patient
$8,175,345
(10.17%↑ Y/Y)
Clinical And Medical
Providers
$3,529,220
(58.17%↑ Y/Y)
Loss before income
taxes
-$3,989,956
(11.01%↑ Y/Y)
Income tax expense
$31,404
(-78.81%↓ Y/Y)
Revenue
$11,704,565
(21.26%↑ Y/Y)
Loss from operations
-$2,254,486
(50.89%↑ Y/Y)
Total other (income),
net
-$1,735,470
(-1728.80%↓ Y/Y)
Gross profit
$8,442,548
(39.50%↑ Y/Y)
Cost of revenue
$3,262,017
(-9.39%↓ Y/Y)
Total operating
expenses
$10,697,034
(0.51%↑ Y/Y)
Change in fair value of
derivatives liabilities
-$1,199,726
Interest expense
(income), net
-$535,744
(-602.81%↓ Y/Y)
Selling, clinical and
marketing
$5,264,090
(0.58%↑ Y/Y)
General and
administrative
$3,712,481
(8.96%↑ Y/Y)
Research and development
$1,720,463
(-14.03%↓ Y/Y)
Buy us a coffee
MYOMO, INC. (MYO)
MYOMO, INC. (MYO)